Generate Biomedicines, Inc. (GENB)
17.71
+1.59
(+9.86%)
USD |
NASDAQ |
Aug 24, 16:00
17.62
-0.09
(-0.51%)
After-Hours: 20:00
Generate Biomedicines Profit Margin (Quarterly) : -1.07K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.07K% |
| March 31, 2026 | -854.3% |
| Date | Value |
|---|---|
| June 30, 2025 | -560.1% |
| March 31, 2025 | -502.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Twist Bioscience Corp. | -29.61% |
| Prime Medicine, Inc. | -3.65K% |
| Intellia Therapeutics, Inc. | -1.39K% |
| Beam Therapeutics, Inc. | -25.04K% |
| Moderna, Inc. | -539.3% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | 48.94% |
| Operating Margin (Quarterly) | -1.13K% |